Veenat 100mg is a tyrosine kinase inhibitor prescribed for chronic myeloid leukemia and gastrointestinal stromal tumors. Its active ingredient, Imatinib, selectively targets cancer cell growth by inhibiting specific proteins. Administered orally, usually with food, the dosage is tailored to the specific cancer type and stage.